Clinical and genetic determinants of torsade de pointes risk.
作者信息
Sauer Andrew J, Newton-Cheh Christopher
机构信息
Center for Human Genetic Research, Cardiovascular Research Center, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA.
出版信息
Circulation. 2012 Apr 3;125(13):1684-94. doi: 10.1161/CIRCULATIONAHA.111.080887.
Abstract
摘要
相似文献
1
Clinical and genetic determinants of torsade de pointes risk.
Circulation. 2012 Apr 3;125(13):1684-94. doi: 10.1161/CIRCULATIONAHA.111.080887.
2
Letter by Sacha regarding article, "clinical and genetic determinants of torsade de pointes risk".
Circulation. 2012 Nov 6;126(19):e309; author reply p. e310. doi: 10.1161/CIRCULATIONAHA.112.114363.
3
Torsade de pointes.
Curr Opin Cardiol. 2003 Jan;18(1):6-13. doi: 10.1097/00001573-200301000-00002.
4
An RyR2 mutation found in a family with a short-coupled variant of torsade de pointes.
Int J Cardiol. 2017 Jan 15;227:367-369. doi: 10.1016/j.ijcard.2016.11.052. Epub 2016 Nov 8.
5
Torsade de pointes: the clinical considerations.
Int J Cardiol. 2004 Jul;96(1):1-6. doi: 10.1016/j.ijcard.2003.04.055.
6
[Cardiac arrhythmias. Torsade de pointes caused by hypokalemia].
MMW Fortschr Med. 2001 Apr 12;143(15):54.
7
Torsade de pointes: an electrophysiological effect of cardiac resynchronization?
Pacing Clin Electrophysiol. 2006 May;29(5):520-2. doi: 10.1111/j.1540-8159.2006.00387.x.
8
Staying in rhythm: identifying risk factors for Torsade de pointes.
Orthopedics. 2005 Dec;28(12):1417-20. doi: 10.3928/0147-7447-20051201-11.
9
Genetic marker of torsades de pointes risk following myocardial infarction.
Heart Rhythm. 2012 Jul;9(7):1113-4. doi: 10.1016/j.hrthm.2012.05.007. Epub 2012 May 8.
10
Torsade de pointes in a child with acute rheumatic fever.
J Pediatr. 2001 Feb;138(2):280-2. doi: 10.1067/mpd.2001.110302.
引用本文的文献
1
Evaluating cardiac disorders associated with triazole antifungal agents based on the US Food and Drug Administration Adverse Event reporting system database.
Front Pharmacol. 2024 Mar 20;15:1255918. doi: 10.3389/fphar.2024.1255918. eCollection 2024.
2
Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy.
Handb Exp Pharmacol. 2023;281:209-233. doi: 10.1007/164_2023_663.
3
Targeted deep sequencing analyses of long QT syndrome in a Japanese population.
PLoS One. 2022 Dec 8;17(12):e0277242. doi: 10.1371/journal.pone.0277242. eCollection 2022.
4
Torsades de pointes following vaccination for COVID-19.
HeartRhythm Case Rep. 2022 Jun;8(6):393-397. doi: 10.1016/j.hrcr.2022.04.003. Epub 2022 Apr 9.
5
Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase.
Eur J Clin Pharmacol. 2021 Oct;77(10):1513-1521. doi: 10.1007/s00228-021-03133-w. Epub 2021 May 3.
6
Sex-Specific Classification of Drug-Induced Torsade de Pointes Susceptibility Using Cardiac Simulations and Machine Learning.
Clin Pharmacol Ther. 2021 Aug;110(2):380-391. doi: 10.1002/cpt.2240. Epub 2021 Apr 19.
7
Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data.
J Cardiovasc Pharmacol Ther. 2021 Jul;26(4):335-340. doi: 10.1177/1074248421995348. Epub 2021 Mar 8.
8
Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine.
Pflugers Arch. 2021 Jul;473(7):1151-1165. doi: 10.1007/s00424-020-02486-y. Epub 2020 Nov 18.
9
Effects of antidepressants on QT interval in people with mental disorders.
Arch Med Sci. 2020 May 29;16(4):727-741. doi: 10.5114/aoms.2019.86928. eCollection 2020.
10
Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data.
PLoS Med. 2020 Mar 5;17(3):e1003040. doi: 10.1371/journal.pmed.1003040. eCollection 2020 Mar.
本文引用的文献
1
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes.
Circ Cardiovasc Genet. 2012 Feb 1;5(1):91-9. doi: 10.1161/CIRCGENETICS.111.960930. Epub 2011 Nov 18.
2
Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology.
J Am Coll Cardiol. 2011 Sep 20;58(13):1309-24. doi: 10.1016/j.jacc.2011.06.029.
3
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome.
Nature. 2011 Mar 10;471(7337):230-4. doi: 10.1038/nature09855. Epub 2011 Feb 9.
4
Modelling the long QT syndrome with induced pluripotent stem cells.
Nature. 2011 Mar 10;471(7337):225-9. doi: 10.1038/nature09747. Epub 2011 Jan 16.
5
Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
N Engl J Med. 2010 Oct 7;363(15):1397-409. doi: 10.1056/NEJMoa0908679. Epub 2010 Jul 21.
6
Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.
J Am Coll Cardiol. 2010 Jun 15;55(24):2745-52. doi: 10.1016/j.jacc.2009.12.065.
7
Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development.
Am Heart J. 2010 May;159(5):716-29. doi: 10.1016/j.ahj.2010.02.004.
8
Relationship of common candidate gene variants to electrocardiographic T-wave peak to T-wave end interval and T-wave morphology parameters.
Heart Rhythm. 2010 Jul;7(7):898-903. doi: 10.1016/j.hrthm.2010.03.002. Epub 2010 Mar 4.
9
A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death.
Circ Cardiovasc Genet. 2010 Apr;3(2):199-206. doi: 10.1161/CIRCGENETICS.109.898569. Epub 2010 Feb 24.
10
Prevalence of the congenital long-QT syndrome.
Circulation. 2009 Nov 3;120(18):1761-7. doi: 10.1161/CIRCULATIONAHA.109.863209. Epub 2009 Oct 19.
Zotero 插件